Muscle Contraction: Too much of a good thing
A mutation that causes heart disease in humans increases the number of active myosin heads during contraction in the muscles of fruit flies, leading to the progressive dysfunction of the flight muscles and heart tube.
- University of Florida, United States
Our muscles help us to move, eat, breathe and pump blood through our body. The skeletal and heart muscles of vertebrates consist of bundles of muscle fibers, with each fiber containing thousands of smaller structures called myofibrils. Within these myofibrils, thick myosin filaments and thin actin filaments can slide past each other to change the length of the muscle. This involves a part of a myosin filament, called the myosin head, 'grabbing hold' of an actin filament.
Controlling the interactions between the myosin heads and actin is a finely tuned and highly regulated process, and even small changes to it can lead to dysfunction and disease. For example, in a condition called hypertrophic cardiomyopathy, mutations in the myosin head can cause the walls of the heart to thicken, ultimately restricting the outflow of blood (Garfinkel et al., 2018). So far, it has been unclear how the mutations can cause these problems. Now, in eLife, Sanford Bernstein, Douglas Swank and colleagues at San Diego State University, Rensselaer Polytechnic Institute and Johns Hopkins University – including William Kronert as first author – report the surprising finding that a mutation in the motor portion of the myosin head that causes human hypertrophic cardiomyopathy can lead to degeneration of the flight muscles as well as the dysfunction of the heart tube in fruit flies (Kronert et al., 2018).
What appears to underlie this seemingly perplexing result is a loss of proper interactions either within myosin heads or, possibly, between the myosin heads and other components of the myosin filament. These interactions normally lead to the myosin heads being packed onto the ‘backbone’ of the myosin filament in a way that restricts their interactions with the actin filaments.
The myosin head contains a motor domain, a regulatory light chain and an essential light chain. The key structural insights into the packing of the myosin heads came from studying the regulation of smooth muscle myosin in vertebrates, which is inactive unless the regulatory light chain is phosphorylated (Wendt et al., 2001). This work revealed asymmetric interactions (known as the 'interacting head motif’) between neighboring myosin heads, which trapped both heads in inactive conformations: the actin binding site of one head was blocked by binding to the other in a way that prevented the latter from releasing the products of ATP hydrolysis when it interacted with actin (Figure 1). Interacting head motifs have also been found in the skeletal muscle of tarantulas, the heart muscles of vertebrates, and even in primitive animals that do not form muscles (Alamo et al., 2016; Woodhead et al., 2005; Lee et al., 2018; Zoghbi et al., 2008).
Figure 1
An interacting head motif.
A schematic view of an interacting head motif: the motor domain of one myosin head (the blocked head, shown in purple) has its actin binding site blocked by interactions with the second head (the free head). The essential light chain (ELC) and regulatory light chain (RLC) of each myosin head are also involved in the formation of the interacting head motif.
In an energy conserving ‘super-relaxed state’, myosin is trapped in a state with very low basal ATPase activity (Stewart et al., 2010). This appears to be a mechanism to stabilize myosin in its ‘pre-powerstroke’ state, in which inorganic phosphate and ADP are confined within the myosin head. Kronert et al. suggest that this pre-powerstroke state is destabilized by the mutation they were studying.
The researchers used fruit flies with a specific mutation on the side of the myosin head, called K146N, which causes thickening of the heart wall in humans. In the flies, the mutation leads to a degenerated heart tube and flight muscles. For both humans and flies, the problem appears to be the same: too many myosin heads interact during contraction and attach to actin for longer than usual, leading to hyperactivation, damage and disorder in the muscle. Myosin was able to create more force, while the movement of actin slowed down. Over time, the increased cost of performing work caused the muscles to degenerate. Although this does not lead to hypertrophy of the flight muscles – as it does in the human heart – there is decreased relaxation and restriction of the heart tube in the flies, paralleling human hypertrophic cardiomyopathy.
The ‘myosin mesa’ theory hypothesizes that many of the mutations causing hypertrophic cardiomyopathy are surface mutations that interfere with the formation and/or stabilization of the interacting head motif (Trivedi et al., 2018). It also proposes that a subset of these mutations might lead to interactions with another protein of the thick filament of the heart muscle, the myosin-binding protein C, which could help stabilize the interactions between the two myosin heads in the interacting head motif. This in turn could explain why mutations in myosin-binding protein C can also cause hypertrophic cardiomyopathy. Based on these concepts, a drug that stabilizes the super-relaxed state and the interacting head motif is being developed for the treatment of human hypertrophic cardiomyopathy (Anderson et al., 2018).
All in all, fruit flies may be a surprisingly good model to test the effects of mutations associated with human hypertrophic cardiomyopathy, apart from those that may interact directly with myosin-binding protein C, which is not present in fruit flies. However, the major significance of the work is that it underscores that since the super-relaxed state and the packing of interacting head motifs onto thick filaments is conserved throughout the evolution of muscle, it is likely that their functions – which would be to control the number of myosin heads available to interact with actin when the muscle is activated, and to lower the energetic cost when the muscle is relaxed – are also conserved.
References
-
Genetic pathogenesis of hypertrophic and dilated cardiomyopathyHeart Failure Clinics 14:139–146.https://doi.org/10.1016/j.hfc.2017.12.004
Article and author information
Author details
Publication history
- Version of Record published: September 17, 2018 (version 1)
Copyright
© 2018, Sweeney
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,053
- Page views
-
- 116
- Downloads
-
- 2
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Muscle Contraction: Too much of a good thing
eLife 7:e41178.
https://doi.org/10.7554/eLife.41178
Further reading
-
- Cell Biology
- Neuroscience
Mitochondria influence cellular function through both cell-autonomous and non-cell autonomous mechanisms, such as production of paracrine and endocrine factors. Here, we demonstrate that mitochondrial regulation of the secretome is more extensive than previously appreciated, as both genetic and pharmacological disruption of the electron transport chain caused upregulation of the Alzheimer’s disease risk factor apolipoprotein E (APOE) and other secretome components. Indirect disruption of the electron transport chain by gene editing of SLC25A mitochondrial membrane transporters as well as direct genetic and pharmacological disruption of either complexes I, III, or the copper-containing complex IV of the electron transport chain elicited upregulation of APOE transcript, protein, and secretion, up to 49-fold. These APOE phenotypes were robustly expressed in diverse cell types and iPSC-derived human astrocytes as part of an inflammatory gene expression program. Moreover, age- and genotype-dependent decline in brain levels of respiratory complex I preceded an increase in APOE in the 5xFAD mouse model. We propose that mitochondria act as novel upstream regulators of APOE-dependent cellular processes in health and disease.
-
- Cell Biology
Uso1/p115 and RAB1 tether ER-derived vesicles to the Golgi. Uso1/p115 contains a globular-head-domain (GHD), a coiled-coil (CC) mediating dimerization/tethering and a C-terminal region (CTR) interacting with golgins. Uso1/p115 is recruited to vesicles by RAB1. Genetic studies placed Uso1 paradoxically acting upstream of, or in conjunction with RAB1 (Sapperstein et al., 1996). We selected two missense mutations in uso1 resulting in E6K and G540S in the GHD that rescued lethality of rab1-deficient Aspergillus nidulans. The mutations are phenotypically additive, their combination suppressing the complete absence of RAB1, which emphasizes the key physiological role of the GHD. In living hyphae Uso1 recurs on puncta (60 sec half-life) colocalizing partially with the Golgi markers RAB1, Sed5 and GeaA/Gea1/Gea2, and totally with the retrograde cargo receptor Rer1, consistent with Uso1 dwelling in a very early Golgi compartment from which ER residents reaching the Golgi recycled back to the ER. Localization of Uso1, but not of Uso1E6K/G540S, to puncta is abolished by compromising RAB1 function, indicating that E6K/G540S creates interactions bypassing RAB1. That Uso1 delocalization correlates with a decrease in the number of Gea1 cisternae supports that Uso1-and-Rer1-containing puncta are where the protein exerts its physiological role. In S-tag-coprecipitation experiments Uso1 is an associate of the Sed5/Bos1/Bet1/Sec22 SNARE complex zippering vesicles with the Golgi, with Uso1E6K/G540S showing stronger association. Using purified proteins, we show that Bos1 and Bet1 bind the Uso1 GHD directly. However, Bet1 is a strong E6K/G540S-independent binder, whereas Bos1 is weaker but becomes as strong as Bet1 when the GHD carries E6K/G540S. G540S alone markedly increases GHD binding to Bos1, whereas E6K causes a weaker effect, correlating with their phenotypic contributions. AlphaFold2 predicts that G540S increases binding of the GHD to the Bos1 Habc domain. In contrast, E6K lies in an N-terminal, potentially alpha-helical, region that sensitive genetic tests indicate as required for full Uso1 function. Remarkably, this region is at the end of the GHD basket opposite to the end predicted to interact with Bos1. We show that unlike dimeric full-length and CTR∆ Uso1 proteins, the GHD lacking the CC/CTR dimerization domain, whether originating from bacteria or Aspergillus extracts and irrespective of whether it carries or not E6K/G540S, would appear to be monomeric. With the finding that overexpression of E6K/G540S and wild-type GHD complement uso1∆, our data indicate that the GHD monomer is capable of providing, at least partially, the essential Uso1 functions, and that long-range tethering activity is dispensable. Rather, these findings strongly suggest that the essential role of Uso1 involves the regulation of SNAREs.
